Printer Friendly

BRIEFLY.

Byline: The Register-Guard

Molecular Probes receives

grant for cancer research

Molecular Probes, the world's leading supplier of fluorescent dyes for biomedical research, has received a $140,000 grant for cancer research.

The company, which has 240 employees at its Eugene headquarters, won a Small Business Innovative Research grant from the National Cancer Institute.

The grant will fund research in collaboration with Dr. Satyabrata Nandi at the University of California, Berkeley, examining the reduced risk of breast cancer following full-term pregnancy in early adulthood.

The grant program was established in 1982 to promote research and development at companies with less than 500 employees. It is the 10th SBIR award received by Molecular Probes.

UO public forum to discuss

economic impact of war

Which corporations have a stake in Iraq, and how might the war and its economic effects be impacting Oregon citizens? Those topics will be explored Tuesday at "The Economics of War" public forum at the University of Oregon.

Speakers will include UO assistant professor Gordon Lafer of the Labor and Education and Research Center; visiting professor Gwyn Kirk, director East Asia, the U.S. and Puerto Rican Women's Network Against Militarism; and Sandra Morgen, director of the UO Center for the Study of Women in Society.

The free, open-to-the-public forum will be at 7 p.m. in 180 Prince Lucien Campbell Hall, 1415 Kincaid St.
COPYRIGHT 2003 The Register Guard
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:METRO; Business
Publication:The Register-Guard (Eugene, OR)
Date:May 3, 2003
Words:226
Previous Article:OBITUARIES.
Next Article:To increase world peace, try to begin from within.


Related Articles
Briefly.
BRIEFLY.
Business Briefly.
Briefly.
BRIEFLY.
Briefly.
Briefly.
Briefly.
Briefly.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |